Abstract
ObjectivesTo examine the impact of ustekinumab (UST) treatment on patient reported outcomes in patients with active psoriatic arthritis (PsA) using week 24 data from two Phase 3 clinical studies, PSUMMIT...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have